Popular Articles
Teeth Whitening

Oregon Legislature Passes Statewide Health Reform Bills
The Oregon state legislature cleared two reform bills that passed its House of Representatives earlier this week, the Portland Oregonian reports. One bill will tax insurers and hospitals up to $500 million over two years to provide "health coverage for 80,000 uninsured children and an additional 35,000 uninsured low-income adults and put the state on a path toward covering all of its more than 600,000 uninsured residents." The state will leverage as much as $1 billion in federal matching funds. "Some of the federal money will be used to pay hospitals what they pay in taxes. Insurers also will get a portion of their tax money back," the Oregonian reports.
generic viagra online
Discovery Of Gene Mutation Responsible For Hereditary Neuroendocrine Tumor
University of Utah researchers and their colleagues have identified the gene that is mutated in a hereditary form of a rare neuroendocrine tumor called paraganglioma (PGL). The gene, called hSDH5, is required for activation of an enzyme complex that plays a critical role in the chemical reactions that take place within cells to convert biochemical energy into usable energy. This study is published in the journal Science
plastic surgery before after
News of the day
Implanted Defibrillators: New Recommendations For Drivers With ICDs
Patients with an Implantable Cardioverter Defibrillator (ICD) have an ongoing risk of sudden incapacitation that might cause harm to others while driving a car. Driving restrictions are imposed making these recommendations an important guideline for patients.
Nutrition

Laparoscopic Radical Versus Partial Nephrectomy For Tumors >4cm: Intermediate-term Oncologic And Functional Outcomes

UroToday.com - Nephron-sparing surgery has become the well-accepted method for treating patients with localized tumor disease of the kidney. Laparoscopic partial nephrectomy (LPN) has evolved such that it is considered equivalent to open partial nephrectomy for tumors 4 cm. They had 110 patients with Stage T1b-T3N0M0 renal cell carcinoma treated with LRN (N=75) or LPN (N=35). As expected the LRN group had larger tumors and more T3a tumors with clear cell pathologic features. The median follow up was 57 months in the LRN group and 44 months in the LPN group. There was no difference between the two treatment groups with regards to overall mortality, cancer-specific mortality, or recurrence rates. However, the LPN group had significantly less reduction in estimated glomerular filtration rate compared to the LRN group. None of the LPN group patients developed second stage chronic kidney disease compared to 12% in the LRN group. Further long term follow up will be necessary to confirm these preliminary findings, but it would appear that even for larger tumors that are organ confined, the nephron-sparing approach is oncologically justified and may be important in maintaining satisfactory renal function. Simmons MN, Weight CJ, Gill IS Urology. 2009 May;73(5):1077-82 10.1016/j.urology.2008.11.059 Written by UroToday.com Contributing Editor Elspeth M. McDougall, MD, FRCSC, MHPE UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):